Serum level of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in acute coronary syndromes and relationship with prognosis; [Akut Koroner Sendromlarda ̇ Insl̈in Benzeri Büyüme Faktörü-I ve ̇ Insülin Benzeri Büyüme Faktörü Baǧlayici Protein-3 Düzeyleri ve Prognozla ̇ Ilişkisi]
dc.contributor.author | Şekuri C. | |
dc.contributor.author | Arslan Ö. | |
dc.contributor.author | Ütük O. | |
dc.contributor.author | Bayturan Ö. | |
dc.contributor.author | Onur E. | |
dc.contributor.author | Tezcan U.K. | |
dc.contributor.author | Tavli T. | |
dc.date.accessioned | 2024-07-22T08:24:24Z | |
dc.date.available | 2024-07-22T08:24:24Z | |
dc.date.issued | 2004 | |
dc.description.abstract | Objective: The aim of the present study was to examine the levels of insulin-like growth factor (IGF-I) and binding protein-3 (IGFBP-3) in acute coronary syndrome (ACS) and their relationship with prognosis. Methods: Thirty patients with ACS (22 male, 8 female) were included in our study. Patient's population included 20 patients with ST elevation myocardial infarction (STEMI) and 10 with non-ST-elevation ACS. Death, re-infarction, revascularization and malignant arrhythmia were monitored during 3 months. Study group was compared with 20 healthy subjects (Controls). Blood samples were collected in the first 24 hours and at the end of third month. Serum IGF-I and IGFBP-3 levels were determined by radioimmunoassay method. Results: We found decreased level of IGF-I only in the STEMI group (105±84 ng/ml vs. 715±150 ng/ml, p<0.0001). There were no significant differences in IGFBP-3 levels between two groups. Serum IGF-I levels were significantly increased after 3rd month in the STEMI group (356±72 ng/ml vs. 105±84 ng/ml, p=0.025). There was no relationship between IGF-I, IGFBP-3 levels and cardiovascular events occurred during 90 days of follow-up. Conclusion: These data allows to suggest that significantly decreased level of IGF-I in STEMI group of ACSs can be used as a marker of myocardial necrosis. There was no relationship between IGF-I level and cardiovascular events occurred in 90 days, so this parameter can not be used as a negative prognostic factor. | |
dc.identifier.issn | 13028723 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19962 | |
dc.language.iso | Turkish | |
dc.subject | Case-Control Studies | |
dc.subject | Cholesterol | |
dc.subject | Cholesterol, HDL | |
dc.subject | Cholesterol, LDL | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Insulin-Like Growth Factor Binding Protein 3 | |
dc.subject | Insulin-Like Growth Factor I | |
dc.subject | Male | |
dc.subject | Middle Aged | |
dc.subject | Myocardial Infarction | |
dc.subject | Prognosis | |
dc.subject | Severity of Illness Index | |
dc.subject | Triglycerides | |
dc.subject | Turkey | |
dc.subject | somatomedin binding protein 3 | |
dc.subject | somatomedin C | |
dc.subject | cholesterol | |
dc.subject | high density lipoprotein cholesterol | |
dc.subject | low density lipoprotein cholesterol | |
dc.subject | somatomedin binding protein 3 | |
dc.subject | somatomedin C | |
dc.subject | triacylglycerol | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | article | |
dc.subject | blood analysis | |
dc.subject | clinical article | |
dc.subject | comparative study | |
dc.subject | controlled study | |
dc.subject | death | |
dc.subject | disease marker | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | heart arrhythmia | |
dc.subject | heart infarction | |
dc.subject | heart muscle ischemia | |
dc.subject | heart muscle necrosis | |
dc.subject | heart reinfarction | |
dc.subject | human | |
dc.subject | male | |
dc.subject | patient monitoring | |
dc.subject | population research | |
dc.subject | prognosis | |
dc.subject | protein blood level | |
dc.subject | radioimmunoassay | |
dc.subject | revascularization | |
dc.subject | ST segment elevation | |
dc.subject | statistical significance | |
dc.subject | blood | |
dc.subject | case control study | |
dc.subject | heart infarction | |
dc.subject | hospitalization | |
dc.subject | metabolism | |
dc.subject | middle aged | |
dc.subject | mortality | |
dc.subject | Turkey (republic) | |
dc.title | Serum level of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in acute coronary syndromes and relationship with prognosis; [Akut Koroner Sendromlarda ̇ Insl̈in Benzeri Büyüme Faktörü-I ve ̇ Insülin Benzeri Büyüme Faktörü Baǧlayici Protein-3 Düzeyleri ve Prognozla ̇ Ilişkisi] | |
dc.type | Article |